Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort ; volume:21 ; number:1 ; day:2 ; month:9 ; year:2019 ; pages:1-9 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (2.9.2019), 1-9, 12.2019
- Creator
-
Liang, Nan
Sun, Mingshu
Sun, Ruixia
Xu, Ting
Cui, Lingling
Wang, Can
Ma, Lidan
Cheng, Xiaoyu
Xue, Xiaomei
Sun, Wenyan
Yuan, Xuan
Zhang, Hui
Li, Hailong
He, Yuwei
Ji, Aichang
Wu, Xinjiang
Li, Changgui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1976-x
- URN
-
urn:nbn:de:101:1-2020022022514725787301
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liang, Nan
- Sun, Mingshu
- Sun, Ruixia
- Xu, Ting
- Cui, Lingling
- Wang, Can
- Ma, Lidan
- Cheng, Xiaoyu
- Xue, Xiaomei
- Sun, Wenyan
- Yuan, Xuan
- Zhang, Hui
- Li, Hailong
- He, Yuwei
- Ji, Aichang
- Wu, Xinjiang
- Li, Changgui
- SpringerLink (Online service)
Other Objects (12)
Experimentelle Bestimmung des Kontaktwärmeübergangs zwischen Graphit und Edelstahl
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
Urate (Urinverbindungen)
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Reveal cell type-specific regulatory elements and their characterized histone code classes via a hidden Markov model
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Experimentelle Bestimmung des Kontaktwärmeübergangs zwischen Graphit und Edelstahl
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
Urate (Urinverbindungen)
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Reveal cell type-specific regulatory elements and their characterized histone code classes via a hidden Markov model
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Experimentelle Bestimmung des Kontaktwärmeübergangs zwischen Graphit und Edelstahl
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
Urate (Urinverbindungen)
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Reveal cell type-specific regulatory elements and their characterized histone code classes via a hidden Markov model
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase